MOTIVATION OF FUTURE HEALTH CARE SPECIALISTS IN PROMOTING SOCIAL WELLBEING OF ELDERLY PEOPLE

Dynamics of ageing of Latvia’s population is faster than in other European Union countries, which has been caused by the social economic situation and immigration of society members. Ageing of society will have a considerable impact on health care in the future. Hence, it is essential to invest resources in the process of the development of health care by educating health care specialists who will be motivated to solve social wellbeing problems in the country in a professional way.Students and lecturers of Riga Stradins University Liepaja branch have been taking part in European Later Life Active Network (ELLAN) project since 2013. In the research done within the framework of the project, Kogan’s attitude scale to elderly people has been made use of, as well as Nolan’s questionnaire was used to learn about the future health care specialists’ attitude and their expectations concerning work with elderly people. Data collected in Latvia in comparison with the rest of the four countries (Ireland, Germany, Italy and Finland) taking part in the project present the lowest level of attitude indicators. The article focuses on the issue of future health care specialists’ motivation and attitude in their professional work with elderly people, as well as, the impact of the environment on promoting the development of positive attitude towards elderly people and work with them during the study process.

Download Full-text

Innovations by and for Patients, and Their Place in the Future Health Care System

Boundaryless Hospital ◽

10.1007/978-3-662-49012-9_19 ◽

2016 ◽

pp. 341-357 ◽

Cited By ~ 4

Author(s):

Leid Zejnilović ◽

Pedro Oliveira ◽

Helena Canhão

Keyword(s):

Health Care ◽

Health Care System ◽

Future Health ◽

The Future ◽

Future Health Care ◽

Care System

Download Full-text

The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease

Inflammatory Bowel Diseases ◽

10.1093/ibd/izz063 ◽

2019 ◽

Vol 25 (10) ◽

pp. 1718-1728 ◽

Cited By ~ 10

Author(s):

Laura E Targownik ◽

Eric I Benchimol ◽

Julia Witt ◽

Charles N Bernstein ◽

Harminder Singh ◽

...

Keyword(s):

Health Care ◽

Health Care Expenditures ◽

Population Based ◽

World Population ◽

Median Cost ◽

Future Health ◽

Before And After ◽

Future Health Care ◽

The Cost ◽

The Impact

Abstract Background Anti–tumor necrosis factor (anti-TNF) drugs are highly effective in the treatment of moderate-to-severe Crohn’s disease (CD) and ulcerative colitis (UC), but they are very costly. Due to their effectiveness, they could potentially reduce future health care spending on other medical therapies, hospitalization, and surgery. The impact of downstream costs has not previously been quantified in a real-world population-based setting. Methods We used the University of Manitoba IBD Database to identify all persons in a Canadian province with CD or UC who received anti-TNF therapy between 2004 and 2016. All inpatient, outpatient, and drug costs were enumerated both in the year before anti-TNF initiation and for up to 5 years after anti-TNF initiation. Costs before and after anti-TNF initiation were compared, and multivariate linear regression analyses were performed to look for predictors of higher costs after anti-TNF initiation. Results A total of 928 people with IBD (676 CD, 252 UC) were included for analyses. The median cost of health care in the year before anti-TNF therapy was $4698 for CD vs $6364 for UC. The median cost rose to $39,749 and $49,327, respectively, in the year after anti-TNF initiation, and to $210,956 and $245,260 in the 5 years after initiation for continuous anti-TNF users. Inpatient and outpatient costs decreased in the year after anti-TNF initiation by 12% and 7%, respectively, when excluding the cost of anti-TNFs. Conclusions Direct health care expenditures markedly increase after anti-TNF initiation and continue to stay elevated over pre-initiation costs for up to 5 years, with only small reductions in the direct costs of non-drug-related health care.

Download Full-text